Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Mucosal Melanoma × Dermatologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 2635 Skin Neoplasms 470 Lymphoma, T-Cell, Cutaneous 456 Carcinoma, Non-Small-Cell Lung 348 Neoplasms 317 Mycosis Fungoides 308 Breast Neoplasms 302 Keratosis, Actinic 295 Carcinoma, Basal Cell 287 Sezary Syndrome 275 Lymphoma, Non-Hodgkin 257 Carcinoma, Renal Cell 255 Lymphoma 254 Neoplasm Metastasis 250 Leukemia, Lymphocytic, Chronic, B-Cell 238 Lymphoma, Large B-Cell, Diffuse 237 Uveal Melanoma 233 Lymphoma, Follicular 233 Hodgkin Disease 223 Lymphoma, Mantle-Cell 222 Precursor Cell Lymphoblastic Leukemia-Lymphoma 221 Lymphoma, B-Cell, Marginal Zone 221 Burkitt Lymphoma 212 Lymphoma, Large-Cell, Immunoblastic 206 Lung Neoplasms 194 Colorectal Neoplasms 186 Ovarian Neoplasms 174 Lymphoma, Large-Cell, Anaplastic 164 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 162 Multiple Myeloma 161

Interventions

camrelizumab 1 apatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03986515 2019-06-14

Apatinib Plus SHR1210 in Advanced Mucosal Melanoma

Henan Cancer Hospital

Phase 2 Unknown

Mucosal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡